bevantolol has been researched along with Ventricular Fibrillation in 2 studies
bevantolol: structure given in first source
bevantolol : A propanolamine that is 3-aminopropane-1,2-diol in which the hydrogen of the primary hydroxy group is substituted by 3-methylphenyl and one of the hydrogens attached to the nitrogen is substituted by 2-(3,4-dimethoxyphenyl)ethyl. A beta1 adrenoceptor antagonist, it has been shown to be as effective as other beta-blockers for the treatment of angina pectoris and hypertension.
Ventricular Fibrillation: A potentially lethal cardiac arrhythmia that is characterized by uncoordinated extremely rapid firing of electrical impulses (400-600/min) in HEART VENTRICLES. Such asynchronous ventricular quivering or fibrillation prevents any effective cardiac output and results in unconsciousness (SYNCOPE). It is one of the major electrocardiographic patterns seen with CARDIAC ARREST.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Verdouw, PD | 2 |
| Van Bremen, RH | 1 |
| Verkeste, CM | 1 |
| Van der Giessen, WJ | 1 |
| Hartog, JM | 1 |
| Saxena, PR | 1 |
| Hugenholtz, PG | 1 |
2 other studies available for bevantolol and Ventricular Fibrillation
| Article | Year |
|---|---|
Antiarrhythmic action and protection of ischaemia myocardium after beta-blockade with bevantolol.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Coronary Disease; Hemodynamics; Propan | 1985 |
Systemic and regional hemodynamic, antiarrhythmic and antiischemic effects of bevantolol in anesthetized pigs.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Cardiac Output; Coronary Disease; Hemo | 1986 |